The 9th Cancer Immunotherapy and Immunomonitoring Conference (CITIM 2027) will take place on May 24–27, 2027, at the Radisson Blu Hotel & Spa, Daugava Riga, in Riga, Latvia.

The international meeting will bring together cancer researchers, immunologists, clinicians, and healthcare professionals to explore developments in tumor immunology, cancer immunotherapy, and immunodiagnostics.

The four-day conference will focus on the tumor immune microenvironment, mechanisms of immune escape, cancer vaccines, cellular immunotherapies, immune biomarkers, and novel therapeutic approaches. Discussions will also address neuroimmune interactions, immunosuppressive pathways, and opportunities to improve treatment responses through immunomodulation.

The scientific programme will feature keynote lectures, plenary sessions, oral presentations, poster discussions, and networking opportunities. CITIM 2027 aims to strengthen collaboration between basic researchers and clinical investigators and accelerate the translation of immunological discoveries into improved cancer treatments.